Would you include any elective nodal stations for cases of T3/T4 node-negative NSCLC staged by PET/CT in which a patient cannot undergo nodal sampling?  

Would your answer differ based on whether the patient is receiving concurrent chemotherapy? Are there other factors that would influence this decision?



Answer from: Radiation Oncologist at Community Practice